Results 161 to 170 of about 7,495 (248)

An international mega-analysis of psychedelic drug effects on brain circuit function. [PDF]

Nat Med
Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, Vollenweider FX, Ramaekers JG, Kuypers K, Araujo DB, Sporns O, Siegel J, Dosenbach N, Nutt DJ, Carhart-Harris RL, Stamatakis EA, Bzdok D.   +26 more
europepmc   +1 more source

Less is more? Antidepressant effects of short-acting psychedelics. [PDF]

Neuropsychopharmacology
Ramaekers JG.
europepmc   +1 more source

Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer's Disease Therapy. [PDF]

Cells
Jarne-Ferrer J, Pallàs M, Griñán-Ferré C, Bellver-Sanchis A.   +3 more
europepmc   +1 more source

Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis. [PDF]

Clin Pharmacokinet
van der Heijden KV, Otto ME, Schoones JW, van Esdonk MJ, Borghans LGJM, van Hasselt JGC, van Gerven JMA, Jacobs G.   +7 more
europepmc   +1 more source

Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review. [PDF]

Cureus
Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J.   +9 more
europepmc   +1 more source

Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report. [PDF]

Cureus
Kermanshah A, Stapleton M, Mauriello CM, Cobas M, Cordoba Torres IT.   +4 more
europepmc   +1 more source

Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]

Cell Rep Med
Avram M, Borgwardt S.
europepmc   +1 more source

The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000-2025. [PDF]

Drug Alcohol Depend Rep
Darke S, Duflou J, Farrell M, Lappin J, Peacock A.   +4 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial. [PDF]

Int J Neuropsychopharmacol
Mueller MJ, Aicher HD, Dornbierer DA, Marten L, Suay D, Meling D, Elsner C, Wicki IA, Müller J, Poetzsch SN, Caflisch L, Hempe A, Steinhart CP, Puchkov M, Kost J, Landolt HP, Seifritz E, Quednow BB, Scheidegger M.   +18 more
europepmc   +1 more source